Clinical trials
Phase 1 Neurofibroma, Plexiform trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| AstraZeneca | 1 |
| Girish Dhall, MD | 1 |
| Indiana University | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Pasithea Therapeutics Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibroma, Plexiform | 8 |
| Neurofibromatosis 1 | 5 |
| Neurofibromatoses | 2 |
| Brain Neoplasms | 1 |
| Central Nervous System Neoplasms | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Promyelocytic, Acute | 1 |
| Neoplasms | 1 |
| Neuroblastoma | 1 |
| Neurofibroma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.